Emerging Trends in Multidisciplinary Research (ICETMR-2020) 15-16 May 2020 at Dhonburi Rajabhat University, Bangkok, Thailand (07-Feb-2020)        |

Journal :   Research Journal of Pharmacy and Technology

Volume No. :   9

Issue No. :  2

Year :  2016

Pages :   135-138

ISSN Print :  0974-3618

ISSN Online :  0974-360X


Allready Registrered
Click to Login

Frequency of CYP1A1*2A Polymorphism in Syrian Children with Acute Lymphoblastic Leukemia

Address:   Roushan Mubarak1*, Shaden Haddad1, Outhman Hamdan2
1Department of Biochemistry and Microbiology, Faculty of Pharmacy, Damascus University
2Department of Pediatric Oncology and Hematology, Faculty of Medicine, Damascus University
*Corresponding Author
DOI No: 10.5958/0974-360X.2016.00022.6

Although acute lymphoblastic leukemia (ALL) is the most common childhood cancer; factors governing susceptibility to this disease have not yet been identified. CYP1A1, a member of the cytochrome P450 (CYP) enzymes, plays a very important role in the metabolism of carcinogens. To explore the contribution of CYP1A1*2A polymorphism to ALL susceptibility, we conducted a case–control analysis in Syrian children. 70 children with acute lymphoblastic leukemia and 45 healthy control were studied. Genomic DNA was extracted, and restriction fragment length polymorphism (RFLP) based PCR was applied followed by digestion with MspI. Among 70 ALL patients, 8.6% were heterozygous for the CYP1A1*2A genotype compared with 4.4% of controls. The differences between the groups were found not to be statistically significant (OR 2.016; 95% CI 0.39-10.46). The results did not show any association between CYP1A1*2A genotypes and risk of ALL in Syrian children.
Cytochrome ,CYP1A1*2A, polymorphism, ALL, susceptibility, PCR- RFLP, Syrian children .
Roushan Mubarak, Shaden Haddad, Outhman Hamdan. Frequency of CYP1A1*2A Polymorphism in Syrian Children with Acute Lymphoblastic Leukemia. Research J. Pharm. and Tech. 9(2): Feb., 2016; Page 135-138.
[View HTML]      [View PDF]

Visitor's No. :   715178